The episodic vestibular syndrome (EVS) is a clinical condition characterized by recurrent dizziness or vertigo that develops acutely (over seconds, minutes, or hours), may be accompanied by nausea, gait instability, nystagmus, or head-motion intolerance. It disappears clinically within 24 hours and is not linked to head motion, head position/posture or body position/posture.
The classification of the episodic vestibular syndrome (EVS) has always been based on clinical symptoms, and no biological markers have been used for its diagnosis.
The Spanish research group has developed a method of diagnostic using proinflammatory cytokines in the episodic vestibular syndrome. The method is orientated to the patient classification that have Episodic Vestibular Syndrome with migraine and/or with hearing-impaired, with specific approaches for the differential diagnostic of Vestibular Migraine (VM) and Meniere's disease (MD).
Vestibular Migraine (VM) or migrainous vertigo is a type of migraine that may or may not cause a headache, but can include a number of debilitating symptoms affecting the ears, vision and balance.
Meniere's disease (MD) is a disorder of the inner ear that can lead to dizzy spells (vertigo) and hearing loss.
The group is looking for the following collaboration:
-License agreement, in the framework of authorizing the interested parties to use the technology.
-Technical cooperation agreement, to collaborate with other research teams, companies or foundations to improve the technologies.